Twitter | Search | |
Search Refresh
JNCI 2h
Identifying novel genetic markers through transcription-wide association study - can this be a path to reducing the burden of pancreatic cancer?
Reply Retweet Like
NatureRevClinOncol 7h
In a transcriptome-wide association study, 25 susceptibility genes, including 14 at 11 novel risk loci, have been identified for pancreatic cancer:
Reply Retweet Like
Targeted Oncology Apr 5
In the neoadjuvant setting, physicians treating resectable pancreatic cancer have more options than ever before. Recently, however, the routine use of radiotherapy has been called into question, leading to a debate between Drs. Tsai & Choti.
Reply Retweet Like
UMN Cancer Survivorship Research Apr 3
We are conducting a study to understand how the is affecting people with by surveying people with and without . Please consider taking our quick survey:
Reply Retweet Like
Liza HOLD THE LINE STAY HOME Bernstein 18h
MUST READ Perspective from : "Between Scylla and Charybdis — Oncologic Decision Making in the Time of Covid-19"
Reply Retweet Like
Targeted Oncology Apr 1
There are more neoadjvuant treatment options for resectable pancreatic cancer than ever before, but routine use of radiotherapy has been called into question in this debate.
Reply Retweet Like
OncLive SOSS Apr 6
. discusses exciting data with PARP inhibitors in pancreatic cancer
Reply Retweet Like
Targeted Oncology Apr 3
PARP inhibitors following platinum-based chemotherapy as well as immunotherapy combinations have shown early signs of efficacy in metastatic pancreatic cancer with homologous recombination deficiency.
Reply Retweet Like
OncLive.com Apr 5
WATCH: Dr. Pant on Choosing Therapy for Frontline and Beyond in Pancreatic Cancer
Reply Retweet Like
OncLive SOSS Apr 7
. discusses the eligibility criteria for up-front surgery in patients with pancreatic cancer
Reply Retweet Like
Targeted Oncology Apr 5
“A person can take tablets as opposed to needing to come into the clinic to receive infusions. It’s a nice quality-of-life consideration for patients in many ways," Dr. O’Reilly said.
Reply Retweet Like
OncLive.com Apr 3
Michael Choti, MD, of discusses the role of radiation therapy in neoadjuvant therapy for resectable pancreatic cancer
Reply Retweet Like
OncLive.com Apr 4
Radiation therapy is not an essential component of neoadjuvant therapy for patients with resectable pancreatic cancer
Reply Retweet Like
Aurora Cancer Care Apr 3
Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study [Feb 4, 2020] Bellini et al. JCO Abstract 651
Reply Retweet Like
Emil Lou, MD, PhD, FACP Apr 4
Replying to @CancerUmn
Cancer patients / cancer advocates - lend us your voices. Our team at the University of Minnesota has a brief online survey to find out what your experiences are during . Please spread the word.
Reply Retweet Like
OncLive.com Apr 5
WATCH: Dr. Simeone on Selecting Patients With Pancreatic Cancer for Neoadjuvant Therapy
Reply Retweet Like
NCI Cancer Stats Apr 2
Got a few minutes? Watch our Did You Know? Video for pancreatic cancer here:
Reply Retweet Like
Targeted Oncology Apr 2
“[Part of the controversy is because] the current National Comprehensive Cancer Network [NCCN] guidelines2 mention borderline resectable pancreas cancer but are less firm on resectable pancreas cancer,” Dr. Tsai said.
Reply Retweet Like
SeleneSeltzer Apr 6
Reply Retweet Like
SeleneSeltzer Apr 6
Reply Retweet Like